Abstract:Background: Hypoalbuminemia is common in congestive heart failure (CHF) patients. Serum albumin is associated with the prognosis of CHF patients. Impact of albumin infusion on prognosis of patients with CHF-hypoalbuminemia overlap remains unclear. We retrospectively investigated the impact of albumin infusion on prognosis of intensive care unit (ICU) patients with CHF-hypoalbuminemia overlap. Methods: We enrolled all patients whose diagnosis included CHF [ICD-9 (international classification of diseases 9) code =428.0] at first ICU admission from the MIMIC III (Medical Information Mart for Intensive Care III) database, and excluded those with missing serum albumin values, with serum albumin >3.4 g/dL or <18 years old. According to the exposure of albumin infusion during hospitalization, patients were stratified into non-albumin and albumin groups. Propensity-score matching (PSM) was performed (1:1 ratio) to control for baseline confounding. Outcome measures were in-hospital mortality as well as length of stay in the ICU (ICU LOS) and the hospital (hospital LOS). Results: There were 3,190 eligible patients in the initial search. Patients with albumin infusion had markedly higher in-hospital mortality (36.42% vs. 21.81%, P<0.001), longer ICU LOS [median 6.93 (3.39-14.82) vs. 3.84 (1.96-8.00) days, P<0.001], and longer hospital LOS [median 17.46 (11.45-28.33) vs. 10.92 (6.81-18.00) days, P<0.001] than those without albumin infusion. The multivariate logistic regression analysis revealed that albumin infusion [odds ratio (OR), 1.509; 95% confidence interval (CI), 1.164-1.957; P=0.002] was significantly associated with increased risk of in-hospital mortality. After PSM, a cohort of 429 pairs of patients was included in the final analysis. Patients with albumin infusion had markedly higher in-hospital mortality (34.97% vs. 27.27%, P=0.015), longer ICU LOS [median 8.43 (4.33-16.28) vs. 6.43 (3.07-13.66) days, P<0.001], and longer hospital LOS [median 16.92 (11.27-28.06) vs. 13.33 (8.00-21.10) days, P<0.001] than those without albumin infusion. The multivariate logistic regression analysis revealed that albumin infusion (OR, 1.594; 95% CI, 1.143-2.223; P=0.006) was significantly associated with increased risk of in-hospital mortality. Conclusions: Albumin infusion increased in-hospital mortality, ICU LOS, and hospital LOS in ICU patients with CHF-hypoalbuminemia overlap.

Effect of hypoproteinemia on mortality of elderly male patients with chronic heart failure

Albumin levels predict survival in patients with heart failure and preserved ejection fraction.

Use of serum albumin and activities of daily living to predict mortality in long-lived individuals over 95 years of age: a population-based study

Human albumin administration is associated with increased in-hospital mortality in heart failure with hypoproteinaemia patients: analysis of MIMIC-III Database

Effect of albumin-globulin score and albumin to globulin ratio on survival in patients with heart failure: a retrospective cohort study in China

Significance of Serum Albumin for Chronic Heart Failure and Its Prognosis

Hypoalbuminaemia Predicts Outcome in Adult Patients with Congenital Heart Disease

Albuminuria and Dipstick Proteinuria for Predicting Mortality in Heart Failure: A Systematic Review and Meta-Analysis.

Impact of albumin infusion on prognosis of intensive care unit patients with congestive heart failure-hypoalbuminemia overlap: a retrospective cohort study

Predictors of Long-Term Mortality in Patients with Acute Heart Failure.

Association Between Glycated Albumin and Adverse Outcomes in Patients with Heart Failure.

Hypoalbuminaemia and One-Year Mortality in Haemodialysis Patients with Heart Failure: A Cohort Analysis

[Association of Plasma Albumin and Hypersensitive C-reactive Protein with 5-Year All-Cause Mortality among Chinese Older Adults Aged 65 and Older from 8 Longevity Areas in China].

Association of albumin to non-high-density lipoprotein cholesterol ratio with mortality in peritoneal dialysis patients

Association Between Serum Albumin and the Length of Hospital Stay Among Patients With Acute Heart Failure

Serum albumin changes and mortality risk of peritoneal dialysis patients

Prognostic role of serum albumin levels in patients with chronic heart failure

Dynamic Serum Albumin and Outcome of Peritoneal Dialysis Patients: A Retrospective Study in China

Correlation Between Nutritional Status and Mortality in Patients with Heart Failure

Impact of Albumin-bilirubin (ALBI) score on the Prognostic Significance of Patients with Heart Failure:A Retrospective Cohort Study

Albumin Level As an Independent Predictive Factor for Adverse Outcomes in COVID-19 Patients: a Retrospective Cohort Study.